366 related articles for article (PubMed ID: 6089554)
1. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
3. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
4. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
5. Endocrine profile in the long-term phase of converting-enzyme inhibition.
Swartz SL; Williams GH; Hollenberg NK; Crantz FR; Moore TJ; Levine L; Sasahara AA; Dluhy RG
Clin Pharmacol Ther; 1980 Oct; 28(4):499-508. PubMed ID: 6250761
[No Abstract] [Full Text] [Related]
6. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
Bauer JH
Am J Med; 1984 Aug; 77(2A):43-51. PubMed ID: 6206722
[TBL] [Abstract][Full Text] [Related]
8. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
Shepherd AN; Campbell BC; Reid JL
J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
[TBL] [Abstract][Full Text] [Related]
9. Effect of captopril on the renin-angiotensin system in hypertensive children.
Friedman AL; Chesney RW
J Pediatr; 1983 Nov; 103(5):806-10. PubMed ID: 6355422
[TBL] [Abstract][Full Text] [Related]
10. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
Riegger GA; Steilner H; Hayduk K; Liebau G
Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
[TBL] [Abstract][Full Text] [Related]
11. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
12. Duration of action and short-term hormonal responses to enalapril (MK 421) in normal subjects.
Given BD; Taylor T; Hollenberg NK; Williams GH
J Cardiovasc Pharmacol; 1984; 6(3):436-41. PubMed ID: 6202969
[TBL] [Abstract][Full Text] [Related]
13. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
[TBL] [Abstract][Full Text] [Related]
14. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
[No Abstract] [Full Text] [Related]
15. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
16. Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.
Jover B; Mimran A
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):209S-214S. PubMed ID: 6099736
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin converting enzyme inhibitor on serum aldosterone and potassium level.
Kamei H; Arakawa K
Jpn Heart J; 1982 Mar; 23(2):191-9. PubMed ID: 7043022
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
[No Abstract] [Full Text] [Related]
19. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
Jover B; Dupont M; Casellas D; Mimran A
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
